CannBioRx Life Sciences Corp. (ATNFW)

USD 0.01

(5.63%)

Revenue Summary of CannBioRx Life Sciences Corp.

  • CannBioRx Life Sciences Corp.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • CannBioRx Life Sciences Corp.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • CannBioRx Life Sciences Corp. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • CannBioRx Life Sciences Corp. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • CannBioRx Life Sciences Corp. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • CannBioRx Life Sciences Corp. reported a quarterly revenue of 166.03 Thousand USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of CannBioRx Life Sciences Corp. (2023 - 2017)

Historical Annual Revenue of CannBioRx Life Sciences Corp. (2023 - 2017)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Revenue Comparison of CannBioRx Life Sciences Corp.

Name Revenue Revenue Difference
BIMI International Medical Inc. 11.83 Million USD 100.0%
China Jo-Jo Drugstores, Inc. 154.54 Million USD 100.0%
Harrow Health, Inc. 8.625% Senior Notes due 2026 130.19 Million USD 100.0%
Harrow Health, Inc. 11.875% Senior Notes due 2027 130.19 Million USD 100.0%
Leafly Holdings, Inc. 42.25 Million USD 100.0%
Leafly Holdings, Inc. 42.25 Million USD 100.0%
LifeMD, Inc. 152.54 Million USD 100.0%
LifeMD, Inc. 152.54 Million USD 100.0%
TRxADE HEALTH, Inc. 8.27 Million USD 100.0%
PetMed Express, Inc. 281.06 Million USD 100.0%
Walgreens Boots Alliance, Inc. 147.65 Billion USD 100.0%